Bromazolam is a designer benzodiazepine that was never approved for medical use but has flooded the illicit drug market, often sold in counterfeit Xanax tablets that look identical to the real thing.
It produces opioid-like sedation, carries a high risk of fatal overdose (especially when combined with fentanyl), and produces benzodiazepine withdrawal that can be life-threatening if stopped abruptly. The DEA placed it on Schedule I on an emergency basis in March 2026.
If you or someone you know has been using it, what you are dealing with requires real clinical attention.
What Is Bromazolam?
Bromazolam is a synthetic designer benzodiazepine, chemically similar to alprazolam, the active ingredient in Xanax, but never approved for medical use anywhere in the world [1]. It was first synthesized in the 1970s during pharmaceutical research and then quietly shelved. It resurfaced on the illicit drug market in Europe around 2016 and began appearing in the United States around 2019.
It was not designed to treat anything. It was designed to mimic the effects of prescription benzodiazepines while evading drug scheduling laws. Law enforcement seizures of bromazolam in the United States increased from fewer than three per year between 2016 and 2018 to 2,142 in 2022 and 2,913 in 2023 [2].
In March 2026, the DEA placed bromazolam on Schedule I on a temporary emergency basis, making manufacture, distribution, and possession without authorization a federal criminal offense.
How Is Bromazolam Getting Into Counterfeit Xanax?
Bromazolam is being pressed into counterfeit pills that are visually indistinguishable from legitimate prescription Xanax tablets with the same color, shape, and markings [2]. Someone who believes they are taking a Xanax bar purchased outside of a pharmacy may be consuming a different and significantly more potent substance with no way of knowing it.
In February 2023, three people in their twenties in Chicago consumed pressed tablets of bromazolam, believing them to be alprazolam. Despite administration of naloxone, they remained unresponsive. All three experienced multiple seizures and required ICU admission and intubation. Two recovered. One developed epilepsy and fell into a coma [2].
Bromazolam is also showing up as an adulterant in fentanyl and other illicit opioids, often without the knowledge of the person using them. Co-detections with fentanyl exceeded 75% of bromazolam-positive samples in forensic analyses [3].
What Does Bromazolam Do to the Body?
Bromazolam works by binding to GABA-A receptors in the brain, the same mechanism as all benzodiazepines, producing sedation, muscle relaxation, anxiety reduction, and, in higher doses, profound sedation and amnesia [1]. Effects typically begin within 15 to 45 minutes and last five to eight hours.
At recreational doses, users describe heavy sedation, euphoria, disinhibition, and memory gaps. At higher doses or in combination with other central nervous system depressants, effects shift rapidly toward respiratory depression, loss of consciousness, and death.
What Does Bromazolam Withdrawal Look Like?
Because bromazolam acts on the same receptor system as all benzodiazepines, withdrawal follows the same general pattern as benzodiazepine withdrawal, with one important distinction: because it is unregulated and dosing is inconsistent, people using bromazolam are often consuming significantly higher and more variable amounts than they realize, which can make physical dependence develop quickly and withdrawal more severe.
Bromazolam withdrawal symptoms include:
- Anxiety and panic attacks
- Insomnia and sleep disruption
- Nausea and gastrointestinal distress
- Sweating and tremors
- Muscle pain and restlessness
- In serious cases, seizures, hallucinations, and psychosis
Treatment for Bromazolam Dependence
Bromazolam dependence is treated clinically in the same framework as benzodiazepine use disorders. That means medically supervised detox with a gradual taper, typically using a longer-acting benzodiazepine like diazepam as a substitution agent, alongside symptom management and close monitoring for seizure risk.
Because bromazolam is unregulated and doses are inconsistent, a comprehensive medical evaluation at intake is essential to understand the true level of physical dependence before a taper plan is developed. People who have been using bromazolam regularly, especially those who obtained it believing it was Xanax, may have no clear sense of how much they have been using or for how long.
The most important thing to know is that this is not a withdrawal to manage alone. The seizure and psychosis risk during benzodiazepine withdrawal, including bromazolam withdrawal, is real, and it requires clinical monitoring to manage safely.
Benzodiazepine and Designer Drug Treatment at Rushton Recovery
If you have been using bromazolam, counterfeit Xanax, or any benzodiazepine and are finding it difficult to stop, Rushton Recovery in South Lyon, Michigan, offers medically supervised detox with around-the-clock clinical monitoring and a residential program built for exactly this level of complexity.
Our medical team has experience managing benzodiazepine dependence and withdrawal in a private, supportive setting on our 30-acre campus near Ann Arbor. We accept Blue Cross Blue Shield and Blue Care Network as in-network carriers and work with most major insurance plans, including Aetna, Cigna, Humana, UnitedHealthcare, Anthem, Carelon, and Magellan.
If you are not sure whether what you have been using contains bromazolam or another designer substance, that uncertainty is itself a reason to have a clinical conversation. Our admissions team verifies your benefits the same day you reach out.
Sources:
[1] Edinoff, A. N., et al. (2022). Novel designer benzodiazepines: Comprehensive review of evolving clinical and adverse effects. Neurology International, 14(3), 648–663.
[2] Ehlers, P. F., et al. (2024). Notes from the field: Seizures, hyperthermia, and myocardial injury in three young adults who consumed bromazolam disguised as alprazolam — Chicago, Illinois, February 2023. MMWR Morbidity and Mortality Weekly Report, 72(52–53), 1392–1393.
[3] Center for Forensic Science Research and Education. (2022). Public alert: Bromazolam prevalence surging across the United States. CFSRE.